| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/02/2010 | CA2772648A1 Antibodies specifically directed to the soluble form of ctla-4 |
| 09/02/2010 | CA2753584A1 Host cells and methods of use |
| 09/02/2010 | CA2753362A1 Reengineering mrna primary structure for enhanced protein production |
| 09/02/2010 | CA2752175A1 Alteration and modulation of protein activity by varying post-translational modification |
| 09/02/2010 | CA2751730A1 Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris |
| 09/01/2010 | EP2224013A1 Methods for the determination of telomerase activity using click chemistry |
| 09/01/2010 | EP2224010A1 Improved gene expression |
| 09/01/2010 | EP2224009A1 Synthesis of sialic acid in plants |
| 09/01/2010 | EP2224006A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 09/01/2010 | EP2224001A1 Improved epitope displaying phage |
| 09/01/2010 | EP2224000A1 Antibody and use thereof |
| 09/01/2010 | EP2223996A1 Transformant transfected with flavin adenine dinucleotide-binding glucose dehydrogenase gene and method for producing flavin adenine dinucleotide-binding glucose dehydrogenase using the same |
| 09/01/2010 | EP2223938A1 Derivatives of exendin |
| 09/01/2010 | EP2223935A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/01/2010 | EP2223931A1 Novel nucleic acid base pair |
| 09/01/2010 | EP2222835A1 Improved bioactive peptide production |
| 09/01/2010 | EP1427815B1 Methods for the industrial production of vaccines |
| 09/01/2010 | EP1408117B1 Glycoprotein and process for producing the same |
| 09/01/2010 | EP1337558B1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 09/01/2010 | EP1305437B1 Expression of biologically active polypeptides in duckweed |
| 09/01/2010 | CN1995065B Fusion protein for suppressing PTTG expression and its coding gene and uses |
| 09/01/2010 | CN1974783B Biocatalytic process for preparing collagen peptide |
| 09/01/2010 | CN1904036B Method of producing three kinds of human alpha alexins by gene engineering bacteria mixed culture |
| 09/01/2010 | CN101821403A Cell for use in the production of exogenous protein, and production process using the cell |
| 09/01/2010 | CN101821400A Chemo-enzymatic peptide synthesis via c-terminal ester interconversion |
| 09/01/2010 | CN101821288A Covalent diabodies and uses thereof |
| 09/01/2010 | CN101820898A Functional humanization of complementarity determining regions (cdrs) |
| 09/01/2010 | CN101818185A Purification process for bacterial cytolysin |
| 09/01/2010 | CN101818181A Method for preparing agricultural chitosan oligosaccharide by enzymolysis and crop nutrition preparation containing chitosan oligosaccharide |
| 09/01/2010 | CN101818167A Method for producing Delta sleeping peptide by utilizing escherichia coli prokaryotic expression system |
| 09/01/2010 | CN101818162A Molecular design of IBDV (Infectious Bursal Disease Virus) antigen epitope and HBcAg (Hepatitis B Core Antigen) chimeric gene |
| 09/01/2010 | CN101818121A Gene expression technique |
| 09/01/2010 | CN101817878A Monomer quick-acting insulin as well as preparing method and application thereof |
| 08/31/2010 | USRE41595 Application of hydrophobic interaction chromatography combination chromatography to the purification of antibody molecule proteins, for purifying monomeric IgG antibody from a mixture of monomeric IgG antibody and at least one of immunoglobulin aggregates; biological substance purification |
| 08/31/2010 | US7786352 Methods for the production of apolipoproteins in transgenic plants |
| 08/31/2010 | US7786287 Hepatitis C virus assay systems |
| 08/31/2010 | US7786286 Microorganismal, outer-membrane, enzymatic polypeptide for use in developing vaccine for prevention and treatment of nesserial infection |
| 08/31/2010 | US7786284 Polynucleotides encoding IL-17 receptor A antigen binding proteins |
| 08/31/2010 | US7786282 Expression vector comprising tumor necrosis factor fusion for use in identifying modulator for treatment of cell proliferaive disorders; antitumor agents |
| 08/31/2010 | US7786281 Protein-deamidating enzyme, microorganism producing the same, gene encoding the same, production process therefor, and use thereof |
| 08/31/2010 | US7786277 Methods for introducing mannose 6-phosphate and other oligosacharides onto glycoproteins |
| 08/31/2010 | US7786275 Identification of a unique core domain of Par-4 sufficient for selective apoptosis induction in cancer cells |
| 08/31/2010 | US7786272 bind to biomarker overexpressed in colon or lung tumor cells |
| 08/31/2010 | US7786271 Antibodies that inhibit TSLP activity |
| 08/31/2010 | US7786270 Humanized FcγRIIB-specific antibodies and methods of use thereof |
| 08/31/2010 | US7786266 Desmocollin 2 (DSC2) specific immunoglobulin for use in prevention and treatment of cell proliferative disorders |
| 08/31/2010 | US7786264 Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof |
| 08/31/2010 | US7786261 protein of an ectodomain of a transforming growth factor beta membrane-bound receptor and a peptide subunit of an alpha -helical coiled-coil; selecting compounds capable of inhibiting ligand binding and kinase activity |
| 08/31/2010 | US7786255 Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof |
| 08/31/2010 | US7786047 an immunoglobulin having determined antigen specificity, and having a variable fragment which is derived from a so-called heavy-chain immunoglobulin having two heavy polypeptide chains capable of recognizing and binding one or several antigens and which is further naturally devoid of light chains |
| 08/31/2010 | US7785903 Variable domain library and uses |
| 08/31/2010 | US7785885 Rescue of plant cell cultures and suspensions after cryopreservation-induced damage |
| 08/31/2010 | US7785881 MAGE-C2 antigenic peptides and uses thereof |
| 08/31/2010 | US7785880 Permitting the increased production of recombinant proteins; culturing; introducing into the cells agents that inhibit senescence or that promote cell survival |
| 08/31/2010 | US7785879 Pregnane X receptor compositions, crystals and uses thereof |
| 08/31/2010 | US7785872 provides combination of the modified signal peptide, increased copy number of the gene, and/or overexpressed Sec4p resulteing in high level secretion of proteins in Pichia |
| 08/31/2010 | US7785856 therapeutic fusion protein comprising amino acid residues 70-952 of human acid alpha-glucosidase (GAA) and a peptide tag; permits M6P-independent targeting of human GAA or GAA-like enzymes to patient lysosomes |
| 08/31/2010 | US7785855 Nucleic acids encoding polypeptides having amylase activity and methods of making and using them |
| 08/31/2010 | US7785849 Cyclic nucleotide-specific phosphodiesterases from Leishmania and uses thereof |
| 08/31/2010 | US7785836 Polynucleotides encoding antigenic and immunogenic determinants of Merozoite surface protein 3 (MSP3) C-terminal polypeptides; malaria |
| 08/31/2010 | US7785835 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |
| 08/31/2010 | US7785833 Methods and means for producing proteins with predetermined post-translational modifications |
| 08/31/2010 | US7785832 Method of protein synthesis |
| 08/31/2010 | US7785830 comprising a polynucleotide encoding a fusion protein that has the signal sequence of the gac gene of Pseudomonas diminuta and a polypeptide of interest, a prokaryotic host cell transformed with such an expression vector and a process for production of a polypeptide of interest using the vector |
| 08/31/2010 | US7785829 polynucleotide encoding a soluble polypeptide; for decreasing inhibition of axonal growth of a central nervous system neuron; neurological diseases, disorders and injuries such as spinal cord injury |
| 08/31/2010 | US7785827 allows and facilitates production and accumulation of tRNAs that are misaminoacylated with nonstandard and noncognate amino acids; can be used to introduce novel amino acids into proteins |
| 08/31/2010 | US7785826 Method for the deacylation of lipopeptides |
| 08/31/2010 | US7785825 Purified enzyme mixture capable of effecting dehydration and cyclization of precursor peptide; medicines; food processing; bioagriculture; drugs and cytotoxicity |
| 08/31/2010 | US7785824 Hydrolysed casein product comprising tripeptides IPP and/or VPP |
| 08/31/2010 | US7785811 Using lutetium label probes to detect tumor secreted antigens and diagnose/prognose cell proliferative disorders |
| 08/31/2010 | US7785803 Antibody diagnostic kits and methods of use |
| 08/31/2010 | US7785791 Polypeptide variants with altered effector function |
| 08/31/2010 | US7785597 generating an immune response, comprising administering to a mammal variable major protein (VMP)-like polypeptides as antigens for immunoprophylaxis, immunotherapy and immunodiagnosis; antibodies; Lyme disease |
| 08/31/2010 | US7785588 Anti-neurturin receptor-A antibody compositions comprising cytokines or neurotrophic factors |
| 08/31/2010 | US7785586 Capable of binding with a wild type HBsAg antigen and with at least one, preferably at least two or more, mutated forms of the HBsAg antigen |
| 08/31/2010 | US7785580 comprising a polypeptide coupled to a non-protein polymer selected from polyethylene glycol or polypropylene glycol, used for the treatment of respiratory system disorders such as asthma; increased plasma half-life |
| 08/31/2010 | CA2480427C Novel potassium-dependent sodium-calcium exchanger |
| 08/31/2010 | CA2290886C Nucleic acid binding proteins |
| 08/31/2010 | CA2281262C Anti-human medullasin monoclonal antibody, process for producing the same and immunoassay using the same |
| 08/31/2010 | CA2217871C Altered polypeptides with increased half-life |
| 08/31/2010 | CA2190371C Receptor for oncostatin m |
| 08/26/2010 | WO2010096681A2 Modifications of cupredoxin derived peptides and methods of use thereof |
| 08/26/2010 | WO2010096673A1 Fermentation broth formulations |
| 08/26/2010 | WO2010096418A2 Antibody molecules having specificity for human ox40 |
| 08/26/2010 | WO2010095461A1 Novel monoclonal antibody, and use thereof |
| 08/26/2010 | WO2010095270A1 Anti-human α9 integrin antibody and use thereof |
| 08/26/2010 | WO2010040134A3 Independently inducible system of gene expression |
| 08/26/2010 | US20100218282 Nucleic acid molecules from rice controlling abiotic stress tolerance |
| 08/26/2010 | US20100218265 Immune system mediator |
| 08/26/2010 | US20100216976 Sodium-independent transporter carrying acidic amino acid and its gene |
| 08/26/2010 | US20100216975 Framework-Shuffling Of Antibodies |
| 08/26/2010 | US20100216974 Binding molecules |
| 08/26/2010 | US20100216870 Novel Genes Encoding a Nystatin Polyketide Synthase and Their Manipulation and Utility |
| 08/26/2010 | US20100216720 Antibodies to troponin i and methods of use thereof |
| 08/26/2010 | US20100216716 Cell-Permeable Peptide Inhibitors Of The JNK Signal Transduction Pathway |
| 08/26/2010 | US20100216191 Method for Manufacturing a Modified Peptide |
| 08/26/2010 | US20100216190 Novel Selection System |
| 08/26/2010 | US20100216189 Synthetic repetitive proteins, the production and use thereof |
| 08/26/2010 | US20100216188 Use of chick beta actin gene intron-1 |
| 08/26/2010 | US20100216187 Amino acid sequences that bind to a desired molecule in a conditional manner |